Myelodysplastic Syndromes
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndromes.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-05-16Clinical Trial Update: Chemotherapy in Treating Patients Who Have Hematologic Cancer [Phase 1]
A Phase 1 chemotherapy trial sponsored by Daiichi Sankyo for leukemia and myelodysplastic syndromes has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-11Clinical Trial Update: A Phase II Trial of Trisenox Plus Thalomid as Treatment in Patients With Myelodysplastic Syndrome [Phase 2]
Phase II trial evaluating the combination of Trisenox (arsenic trioxide) and thalidomide in myelodysplastic syndromes has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-05-04Clinical Trial Update: RAD001(Everolimus) in Treating Patients With Myelodysplastic Syndromes [Phase 2]
Phase 2 clinical trial evaluating everolimus (RAD001) in patients with myelodysplastic syndromes was terminated.
-
CLINICAL_TRIALS trial_result · 2012-04-23Clinical Trial Update: A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine [Phase 1]
Phase I dose-escalation study of oral SB939 alone or with azacitidine has completed, assessing safety/dosing in solid tumors and hematologic…
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: A Phase 1/2 Study of SB1518 for the Treatment of Advanced Myeloid Malignancies [Phase 1, Phase 2]
This document provides an update on the completed Phase 1/2 trial of SB1518 for advanced myeloid malignancies.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: Azacitidine, Darbepoetin Alfa, and Erythropoietin and Filgastrim (G-CSF) in Treating Patients With Myelodysplastic Syndromes [Phase 2]
Phase 2 trial of azacitidine, darbepoetin alfa, erythropoietin, and G-CSF in myelodysplastic syndromes; study terminated with posted results…
-
CLINICAL_TRIALS trial_result · 2012-04-06Clinical Trial Update: Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies [Phase 1, Phase 2]
This clinical trial update reports safety and early efficacy data for unrelated cord blood transplantation in adults with hematologic malign…
-
CLINICAL_TRIALS trial_result · 2012-03-27Clinical Trial Update: Dose Escalation, Safety and Pharmacokinetic Study of SAR103168 in Patients Refractory/ Relapsed Acute Leukemias or High-risk Myelodysplastic Syndromes [Phase 1]
Phase 1 dose-escalation and safety/pharmacokinetic study of SAR103168 in patients with refractory/relapsed acute myeloid leukemia and high-r…
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer [Phase 2]
A Phase 2 trial evaluating umbilical cord blood transplantation for high-risk hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation
This completed clinical trial evaluated caregiver support and its effect on the quality of life of patients receiving donor bone marrow tran…
-
CLINICAL_TRIALS trial_result · 2012-03-13Clinical Trial Update: Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders. [Phase 1]
A pediatric pharmacokinetic study of Glivec/Gleevec (imatinib) in children aged 1 to less than 4 with chronic myeloid leukemia, Philadelphia…
-
CLINICAL_TRIALS trial_result · 2012-03-09Clinical Trial Update: Autoantibodies Against Human Recombinant Erythropoietin in Myelodysplatic Syndrome Patients
An update on a clinical trial evaluating autoantibody formation against recombinant human erythropoietin in patients with myelodysplastic sy…
-
CLINICAL_TRIALS trial_result · 2012-03-09Clinical Trial Update: Early Recognition of Pulmonary Arterial Hypertension in Myelodysplastic and Myeloproliferative Diseases
This completed clinical trial from Medical University of Graz explored early recognition of pulmonary arterial hypertension in patients with…
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: A Phase 1 Dose Escalating Trial of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplasia [Phase 1]
This update reports results from a Phase 1 dose-escalation study evaluating the combination of bortezomib and lenalidomide in patients with …
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies [Phase 1]
Phase 1 trial assessing T-cell-depleted allogeneic stem cell transplantation after immunoablative induction chemotherapy and reduced-intensi…
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: Search for Predictive Markers of Efficacy of ESAs in Patients With Non-myeloid Malignancies or Myelodysplastic Syndrome
A clinical trial assessing predictive markers of erythropoiesis-stimulating agents in patients with non-myeloid malignancies or myelodysplas…
-
CLINICAL_TRIALS trial_result · 2012-02-15Clinical Trial Update: Blood Samples to Evaluate Biomarkers of Donor Chimerism
The document summarizes a completed trial examining blood-based biomarkers of donor chimerism. The study involves patients with hematologic …
-
CLINICAL_TRIALS trial_result · 2012-01-26Clinical Trial Update: Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation [Phase 2]
A Phase 2 study evaluating sirolimus with tacrolimus for graft-versus-host disease prophylaxis after unrelated donor stem cell transplantati…
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: A Phase II Study of Maintenance With Azacitidine in MDS Patients [Phase 2]
Phase II study evaluating maintenance azacitidine in patients with myelodysplastic syndromes and acute myeloid leukemia; the trial status is…
-
CLINICAL_TRIALS trial_result · 2012-01-13Clinical Trial Update: Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS [Phase 2]
This Phase 2 trial studied selective T-cell depletion in stem cell transplantation to reduce graft-versus-host disease. It included patients…
-
CLINICAL_TRIALS trial_result · 2012-01-05Clinical Trial Update: Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia [Phase 1]
This Phase 1 safety study of MultiStem in patients with acute myeloid leukemia, chronic myeloid leukemia, or myelodysplastic syndromes has c…
-
CLINICAL_TRIALS trial_result · 2011-12-08Clinical Trial Update: Non-Ablative Allo HSCT For Hematologic Malignancies or SAA [Phase 2]
Phase 2 trial update evaluating non-ablative allogeneic hematopoietic stem cell transplantation for hematologic malignancies and severe apla…
-
CLINICAL_TRIALS trial_result · 2011-12-08Clinical Trial Update: A Trial of Bevacizumab in Myelodysplastic Syndromes (Int-1, Int-2 and High Risk According to International Prognostic Scoring System (IPSS)) With Excess of Marrow Blasts [Phase 2]
A Phase 2 trial evaluating bevacizumab in myelodysplastic syndromes with excess marrow blasts has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-11-30Clinical Trial Update: Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
This Phase 2 clinical trial update reports on bone marrow transplantation as a treatment for hematologic cancers, including leukemia, lympho…
-
CLINICAL_TRIALS trial_result · 2011-11-30Clinical Trial Update: Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes [Phase 1, Phase 2]
This completed Phase 1/2 trial evaluated arsenic trioxide in combination with etanercept for myelodysplastic syndromes.